• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORP. GEL-ONE; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORP. GEL-ONE; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Lot Number 0017Z14G
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem No Information (3190)
Event Type  malfunction  
Event Description
The luer lock tip dislodged from the body of the syringe at the end of adminstration by an experienced nurse practitioner (lot #0017z14g).Patient received full amount.Strength: 10 mg/ml - milligrams per millilitres.Dose or amount: 30 mg milligrams.Route: intra-articular.Therapy start date: (b)(6) 2018.Therapy end date: (b)(6) 2018.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GEL-ONE
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORP.
MDR Report Key7600523
MDR Text Key111199655
Report NumberMW5077833
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date01/31/2019
Device Lot Number0017Z14G
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/13/2018
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
-
-